Clinical Trial Update: Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow Transplant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating CG53135-05 for preventing oral mucositis in patients receiving a bone marrow transplant reports on safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Mucositis

Drugs mentioned

• CG53135-05

Snippet

Sponsor: CuraGen Corporation | Conditions: Stomatitis | Phase 2 | Status: COMPLETED